Table 3.
Physician-reported adherence | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total patients (N = 214) | Schizophrenia diagnosis codes only (n = 44) | Bipolar disorder diagnosis codes only (n = 162) | |||||||||||||
Adherence | Adherence | Adherence | |||||||||||||
Claims-based | Low (0–30%) | Moderate (31–70%) | High (71–100%) | Kappa coeffi-cient | p value | Low (0–30%) | Moderate (31–70%) | High (71–100%) | Kappa coeffi-cient | p value | Low (0–30%) | Moderate (31–70%) | High (71–100%) | Kappa coeffi-cient | p value |
Low adherence (0–30%) | 5 | 12 | 32 | 0.0572 | .1908 | 0 | 0 | 7 | 0.0088 | .9089 | 4 | 12 | 24 | 0.0478 | .3522 |
Moderate adherence (31–70%) | 2 | 13 | 50 | 0 | 1 | 9 | 2 | 12 | 38 | ||||||
High adherence (71–100%) | 0 | 19 | 81 | 0 | 2 | 25 | 0 | 17 | 53 |
Kappa coefficient assesses the degree of agreement between physician-reported adherence and claims-based adherence; a large Kappa indicates a strong level of agreement. The Kappa test is used to test the null hypothesis of no agreement. The small value of Kappa and p value indicate no agreement between physician-reported adherence and claims-based adherence. There are eight patients with both schizophrenia and bipolar disorder diagnosis codes that are included only in the total patients’ adherence part of the above table.